Results 71 to 80 of about 18,836 (198)

Development of UPLC-MS/MS Method for Studying the Pharmacokinetic Interaction Between Dasatinib and Posaconazole in Rats

open access: yesDrug Design, Development and Therapy, 2021
Suili Yang,1,* Xiaoshan Zhang,2,3,* Yuzhen Wang,2,3 Congcong Wen,4 Chenxiang Wang,3 Ziye Zhou,5 Guanyang Lin3 1Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China ...
Yang S   +6 more
doaj  

Real‐World Survival Outcomes of Venetoclax Combination Therapies in Acute Myeloid Leukemia: Impact of Minimal Residual Disease Status and Antifungal Prophylaxis [PDF]

open access: yesHematol Oncol
ABSTRACT In recent years the addition of the oral BCL2 inhibitor venetoclax to hypomethylating agents (HMAs) has emerged as the standard‐of‐care for patients with acute myeloid leukemia (AML) who are not fit for intensive chemotherapy, significantly improving survival and quality‐of‐life.
Sciumè M   +9 more
europepmc   +2 more sources

Pharmacokinetic and Pharmacodynamic Interactions Between Anti‐Asthma Drugs and Medicinal Plants: A Comprehensive Review

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6418-6449, November 2026.
ABSTRACT Asthma affects 260–300 million people worldwide. About 20%–35% of patients use medicinal plants with their asthma medication, often without telling their clinicians. Disclosure rates are low; up to 42% of asthma outpatients use herbal products, with no records in their charts.
Emine Kocyigit   +5 more
wiley   +1 more source

Combinations of posaconazole and tacrolimus are effective against infections with azole-resistant Aspergillus fumigatus

open access: yesFrontiers in Cellular and Infection Microbiology
BackgroundSolid organ transplant recipients on immunosuppressants such as tacrolimus are at increased risk of developing pulmonary aspergillosis, a severe to deadly complication with limited treatment options, especially against azole-resistant strains ...
Eliane Vanhoffelen   +10 more
doaj   +1 more source

Right Angle, Wrong Assumptions: A Case of Endobronchial Mucormycosis Presenting as a Pedunculated Mass Mimicking Malignancy

open access: yesRespirology Case Reports, Volume 14, Issue 11, November 2026.
We report a case of endobronchial pulmonary mucormycosis presenting as a pedunculated endobronchial mass in a patient with poorly controlled Type 2 diabetes mellitus and chronic obstructive pulmonary disease. The lesion was initially suspected to be lung cancer, highlighting the importance of considering mucormycosis in the differential diagnosis of an
Rabbia Abbas   +6 more
wiley   +1 more source

Disseminated Fusariosis Occurring in Two Patients Despite Posaconazole Prophylaxis

open access: yes, 2011
Posaconazole is widely used for prophylaxis against invasive fungal infections in patients undergoing myeloablative therapy. Disseminated fusariosis is a serious invasive mold infection in such patients. Preclinical and clinical studies indicate activity
Jennifer L. Holter   +3 more
core   +1 more source

Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease [PDF]

open access: yes, 2015
BACKGROUND: Posaconazole exposure seems to be subtherapeutic in some patients with invasive fungal disease. Due to the pharmacokinetic variability of posaconazole, therapeutic drug monitoring may help to optimize the efficacy of this antifungal drug ...
Span, Lambert F. R.   +9 more
core   +1 more source

Successful treatment of azole-resistant invasive aspergillosis in a bottlenose dolphin with high-dose posaconazole

open access: yesMedical Mycology Case Reports, 2017
Invasive aspergillosis due to azole-resistant Aspergillus fumigatus is difficult to manage. We describe a case of azole-resistant invasive aspergillosis in a female bottlenose dolphin, who failed to respond to voriconazole and posaconazole therapy.
Paulien E. Bunskoek   +7 more
doaj   +1 more source

Histone deacetylase inhibitors as venetoclax‐sensitising partners in acute myeloid leukaemia: Mechanisms, pharmacology and translational perspectives

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 21, Page 6261-6290, November 2026.
Abstract Venetoclax combined with hypomethylating agents has improved treatment for older or unfit patients with acute myeloid leukaemia (AML), but resistance and relapse remain common. This review analyses the rationale for combining venetoclax with inhibitors of histone deacetylase (HDAC).
Jaebok Lee, Marc Diederich
wiley   +1 more source

Pronounced Reductions in Plasma Citrulline Indicate Severe Intestinal Mucosal Barrier Injury During Induction Therapy for Pediatric Acute Myeloid Leukemia

open access: yesEuropean Journal of Haematology, Volume 117, Issue 5, Page 1275-1284, November 2026.
ABSTRACT Objectives Pediatric acute myeloid leukemia (AML) chemotherapy regimens are frequently burdened by fever episodes, systemic inflammation and bloodstream infections (BSI). Mucosal barrier injury may contribute to these complications, but its role in childhood AML remains uninvestigated.
Carla Warley Kjær   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy